Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes

European Journal of Haematology

Volumn 86, Issue 1, 2011, Pages 87-90

  Dargent, Jean Louis ^a   Mathieux, Valérie ^b   Vidrequin, Sébastien ^a   Deghorain, Xavier ^a   Vannuffel, Pascal ^a   Rack, Katrina ^a  

^a INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^b Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD61 ANTIGEN; CD68 ANTIGEN; GLYCOPHORIN A; HUMAN AUTOANTIGEN PERICENTRIOLAR MATERIAL; HYDROXYUREA; JANUS KINASE 2; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; BASOPHIL; BLOOD ANALYSIS; BONE MARROW; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; DYSPNEA; EOSINOPHIL COUNT; ERYTHROBLAST; ERYTHROPOIESIS; FATIGUE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC ASSOCIATION; GRANULOCYTE; HEMATOCRIT; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; MACROCYTIC ANEMIA; MACROPHAGE; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL COUNT; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA; SPLEEN; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT; WEIGHT REDUCTION;

AUTOANTIGENS; BONE MARROW; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MYELODYSPLASTIC-MYELOPROLIFERATIVE DISEASES; SPLEEN; TRANSLOCATION, GENETIC;

EID: 78650110657     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01525.x     Document Type: Letter

References (12)

1. Reiter A, Walz C, Watmore A, et al. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 2005;65:2662-7.
2. Bousquet M, Quelen C, De Mas V, Duchayne E, Roquefeuil B, Delsol G, Laurent G, Dastugue N, Brousset P. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukemia yields a new PCM1-JAK2 fusion gene. Oncogene 2005;24:7248-52.
3. Murati A, Gelsi-Boyer V, Adelaïde J, et al. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia 2005;19:1692-6.
4. Heiss S, Erdel M, Gunsilius E, Nachbaur D, Tzankov A. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case. Hum Pathol 2005;36:1148-51.
5. Thiele J, Kvasnicka HM, Facchetti F, Franco V, Van der Walt J, Orazi A. European consensus for grading of bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90:1128-32.
6. Smith CA, Fan G. The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms. Hum Pathol 2008;39:795-810.
7. Adelaïde J, Pérot C, Gelsi-Boyer V, Pautas C, Murati A, Copie-Bergman C, Imbert M, Chaffanet M, Birnbaum D, Mozziconacci MJ. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma. Leukemia 2006;20:536-7.
8. Huang KP, Chase AJ, Cross NCP, Reiter A, Li TY, Wang TF, Chu SC, Lu XY, Li CC, Kao RH. Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia. Int J Hematol 2008;88:197-201.
9. Najfeld V, Cozza A, Berkofsy-Fessler W, Prchal J, Scalise A. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms. Exp Hematol 2007;35:1668-76.
10. Patnaik MM, Knudson RA, Gangat N, Hanson CA, Pardanani A, Tefferi A, Ketterling RP. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates. Eur J Haematol 2010;84:518-24.
11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: IARC Press; 2008:76-86.
12. Kennedy JA, Barabé F, Patterson BJ, Bayani J, Squire JA, Barber DL, Dick JE. Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo. PNAS 2006;103:16930-5.